-+ 0.00%
-+ 0.00%
-+ 0.00%

MIRA PHARMACEUTICALS - FDA CONFIRMS ACCEPTANCE OF PHASE 2A CLINICAL TRIAL PROTOCOL FOR PROTOCOL MIRA-2 - SEC FILING

Reuters·06/17/2026 12:04:31

Please log in to view news